OpenAlexmetadata only
Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled Trial
Medicine, Women's Health Initiative, Medroxyprogesterone acetate, Hazard ratio, Randomized controlled trial, Placebo
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 6846
Conceptio Open Knowledge Archive — every document is proof-bundled with source, license, and retrieval metadata.